Highlights and Quick Summary
- Financing cash flow for the quarter ending September 30, 2022 was $145 Thousand (a -1711.11% decrease compared to previous quarter)
- Year-over-year quarterly Financing cash flow decreased by -96.68%
- Annual Financing cash flow for 2021 was $5.45 Million (a -95.77% decrease from previous year)
- Annual Financing cash flow for 2020 was $129 Million (a -1.76% decrease from previous year)
- Annual Financing cash flow for 2019 was $131 Million (a 9.04% increase from previous year)
- Twelve month Financing cash flow ending September 30, 2022 was $8.28 Million (a -2.31% decrease compared to previous quarter)
- Twelve month trailing Financing cash flow increased by 51.96% year-over-year
Trailing Financing cash flow for the last four month:
| 30 Sep '22 | 30 Jun '22 | 31 Mar '22 | 31 Dec '21 |
|---|---|---|---|
| $8.28 Million | $8.47 Million | $8.5 Million | $5.45 Million |
Visit stockrow.com/BCEL
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Financing cash flow of Atreca, Inc.
Most recent Financing cash flowof BCEL including historical data for past 10 years.Interactive Chart of Financing cash flow of Atreca, Inc.
Atreca, Inc. Financing cash flow for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | $0.15 | $-0.01 | $3.77 | – |
| 2021 | $4.37 | $0.34 | $0.02 | $0.71 | $5.45 |
| 2020 | $0.44 | $126.96 | $0.53 | $0.94 | $128.87 |
| 2019 | $0.04 | $-2.13 | $133.32 | $-0.06 | $131.17 |
| 2018 | – | $0.0 | $120.32 | $-0.01 | $120.3 |
| 2017 | – | – | – | – | $34.29 |
Business Profile of Atreca, Inc.
Sector: Healthcare
Industry: Biotechnology